Enimmune Corporation (TPEX:6564)

Taiwan · Delayed Price · Currency is TWD

18.95

0.00 (0.00%)

At close: May 8, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Trading of Vaccines and Testing Reagents	48.19M	39.92M	43.49M	188.42M	109.82M
Trading of Vaccines and Testing Reagents Growth	20.74%	-8.23%	-76.92%	71.56%	380.08%
Total	48.19M	39.92M	43.49M	188.42M	109.82M
Total Growth	20.74%	-8.23%	-76.92%	71.56%	380.08%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	48.19M	39.92M	43.49M	187.50M	109.76M
Taiwan Growth	20.74%	-8.23%	-76.80%	70.83%	379.79%
Hong Kong	-	-	-	916.00K	-
Japan	-	-	-	-	17.00K
Singapore	-	-	-	-	49.00K
Total	48.19M	39.92M	43.49M	188.42M	109.82M
Total Growth	20.74%	-8.23%	-76.92%	71.56%	380.08%

Source: S&P Global Market Intelligence.